{
    "nctId": "NCT06455904",
    "briefTitle": "Effects Of Concentric Cycling Training Protocol During (Neo)Adjuvant Chemotherapy in Breast Cancer Patients: PROTECT-07 Study",
    "officialTitle": "Effects Of Concentric Cycling Training Protocol During (Neo)Adjuvant Chemotherapy in Breast Cancer Patients: PROTECT-07 Study",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 156,
    "primaryOutcomeMeasure": "Overall exercise capacity",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Woman \u2265 18 years old\n* Stage I to III breast cancer\n* Patient currently planning (neo)adjuvant treatment combining anthracycline-cyclophosphamide and weekly paclitaxel (\u00b1 trastuzumab)\n* Affiliation to a social security system\n* Able to speak, read and understand French\n\nExclusion Criteria:\n\n* No prior chemotherapy treatment\n* Any known cardiac or vascular pathology\n* Contraindications to physical fitness assessment\n* Protected adult\n* Psychiatric, musculoskeletal or neurological problems\n* Pregnant or breastfeeding woman (NB: this population is already subject to a contraindication to (neo)adjuvant treatment. For women of childbearing age, a betaHCG dosage is already carried out systematically before the start of chemotherapy and information on the need for contraception throughout the chemotherapy period is provided before the start of treatment. As part of this study, only the presence of this test with a negative result at the start of chemotherapy will be checked. inclusion, if available).",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}